Correlation Between OMX Stockholm and Neola Medical

Can any of the company-specific risk be diversified away by investing in both OMX Stockholm and Neola Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OMX Stockholm and Neola Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OMX Stockholm Mid and Neola Medical AB, you can compare the effects of market volatilities on OMX Stockholm and Neola Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OMX Stockholm with a short position of Neola Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of OMX Stockholm and Neola Medical.

Diversification Opportunities for OMX Stockholm and Neola Medical

0.23

Correlation Coefficient

OMX Stockholm  Neola Medical

Modest diversification

The 3 months correlation between OMX and Neola is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding OMX Stockholm Mid and Neola Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neola Medical AB and OMX Stockholm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OMX Stockholm Mid are associated (or correlated) with Neola Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neola Medical AB has no effect on the direction of OMX Stockholm i.e., OMX Stockholm and Neola Medical go up and down completely randomly.

Pair Corralation between OMX Stockholm and Neola Medical

Assuming the 90 days trading horizon OMX Stockholm Mid is expected to generate 0.16 times more return on investment than Neola Medical. However, OMX Stockholm Mid is 6.33 times less risky than Neola Medical. It trades about 0.02 of its potential returns per unit of risk. Neola Medical AB is currently generating about -0.04 per unit of risk. If you would invest  165,306  in OMX Stockholm Mid on September 8, 2024 and sell it today you would earn a total of  1,330  from holding OMX Stockholm Mid or generate 0.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.48%
Values	Daily Returns

OMX Stockholm Mid  vs.  Neola Medical AB

Pair Trading with OMX Stockholm and Neola Medical

The main advantage of trading using opposite OMX Stockholm and Neola Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OMX Stockholm position performs unexpectedly, Neola Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neola Medical will offset losses from the drop in Neola Medical's long position.

The idea behind OMX Stockholm Mid and Neola Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.